Although there was not any significant association between GDF3 expression and other clinicopathological aspects such as tumor stage, grade of differentiation, and lymph node metastasis, 4 of 7 GDF3 overexpressed tumors (57.1%) were in advanced stages (III/IV), MD, showing lymph node metastasis. The gene discussed is GDF3; the disease is neoplasm.